Truist Securities adjusted its outlook for Sangamo BioSciences, reducing the price target on the company's shares to $5 from ...
Hexcel Corporation reported its fourth-quarter 2024 earnings, showcasing a strong performance with an adjusted earnings per share (EPS) of $0.52, surpassing the forecasted $0.50. The company's revenue ...